R1 Secures Investment from Khosla Ventures
R1, a Murray, Utah-based healthcare revenue management automation solutions provider, has secured an investment from Khosla Ventures.
Khosla Ventures is a private venture capital firm based in Menlo Park, California. Founded in 2004, the firm focuses on investments in artificial intelligence, financial services, healthcare, consumer, enterprise, and sustainability sectors.
The company will use the funding to accelerate the development and deployment of its R37 AI Lab, enhancing agentic AI applications that automate revenue cycle workflows for healthcare providers.
R1 is a healthcare technology company specializing in revenue cycle management (RCM). By leveraging AI, R1 helps healthcare providers manage and automate their financial workflows to improve efficiency and reduce administrative costs. It utilizes 20,000 proprietary automation algorithms to streamline labor-intensive tasks such as coding, billing, and denials management. The company recently launched R37, an enterprise-grade AI lab developed in partnership with Palantir, designed to strengthen healthcare providers’ financial health through advanced agentic AI applications. Headquartered in Murray, Utah, the company serves 94 of the top 100 U.S. health systems.
Funding Details
Company: R1
Raised: Undisclosed
Round: Unknown
Funding Date: May 2025
Investor: Khosla Ventures
Company Website: https://www.r1rcm.com/
Software Category: Healthcare Revenue Cycle Management, AI FinTech